Dr. Paul F. Dellaripa, MD

  • Boston, MA
  • Rheumatologist
NPI1093727950PAC ID3678477312
Medicare services, 2024
736
Medicare patients, 2024
430
Part D claims, 2024
2,021
Publications
75
Clinical trials
3
Practice address
75 Francis Street, Boston, MA 02115
Practice phone
Call (617) 732-5500
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Brigham and Women's Hospital

Hospital · Boston, Massachusetts

See all 10 affiliations

Find Dr. Dellaripa's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Paul F. Dellaripa is a rheumatologist in Boston, Massachusetts

Dr. Dellaripa practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Dellaripa's NPI, 1093727950, was assigned on August 12, 2006. Dr. Dellaripa graduated from University of Connecticut School of Medicine in 1989. Dr. Dellaripa holds Massachusetts license 76216.

NPI and contact details
Medicare PAC ID
3678477312
NPI enumeration date
August 12, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(617) 732-5500
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
63
Medical school graduation
1989

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Paul F. Dellaripa practices at Brigham and Women's Hospital in Boston, Massachusetts

Dr. Dellaripa's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Source: Dmand AI Affiliation Data

Dr. Paul F. Dellaripa is affiliated with 7 sites of care and 3 medical groups

Dr. Dellaripa's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Dellaripa is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Dellaripa to 3 more hospitals, 2 medical groups, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

See all 10 affiliations for Dr. Dellaripa

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Paul F. Dellaripa's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dellaripa practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Brigham and Women's HospitalAvailable with a free account
+6 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Dellaripa practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Mass General Brigham and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Paul F. Dellaripa is one of 275 rheumatologists in Massachusetts

Rheumatology is Dr. Dellaripa's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Dellaripa is licensed in Massachusetts.

Specialties and state licenses

  • Rheumatology, MassachusettsPrimaryLicense 76216 · taxonomy 207RR0500X

Rheumatologists near Dr. Dellaripa

Counts of rheumatologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Paul F. Dellaripa billed Medicare for 736 services in 2024

CMS data shows 736 Medicare services from Dr. Dellaripa across 10 procedure codes in 2024, for 430 Medicare patients. Medicare paid $49,708 for them.

Medicare services, 2024736
Medicare patients430
Paid by Medicare$49,708
Procedure codes10

Dr. Dellaripa's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 7652024: 7206%
Surgery
2023: 02024: 16

Where Dr. Dellaripa's Medicare services took place, 2024

  • In an office30241%
  • In a facility43459%

Dr. Dellaripa compared with the Massachusetts median for rheumatologists, 2024

  • Dr. Dellaripa
  • Massachusetts median
Medicare services
736vs 41279% above
Medicare patients
430vs 2092.1 times
Part D claims
1,780vs 5053.5 times

Medians across 268 rheumatologists in Massachusetts with Dmand AI profiles that report each measure.

Dr. Dellaripa's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Dellaripa

Need commercial claims for Dr. Dellaripa?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Dellaripa and other rheumatologists in Massachusetts.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Paul F. Dellaripa treated 430 Medicare patients in 2024, average age 73

CMS counts 430 Medicare patients who saw Dr. Dellaripa in 2024. The largest group is 65 to 74, with 188 patients. 73% of them have arthritis, and 71% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dellaripa's median patient age at 71, with 67% women.

Medicare patients, 2024430
Average age73
Average risk score1.68
Also on Medicaid19%

Dr. Dellaripa's Medicare patients by age, 2024

Dr. Dellaripa's Medicare patients by sex, 2024

  • Women29067%
  • Men14033%

Chronic conditions among Dr. Dellaripa's Medicare patients, 2024

  1. Arthritis73%
  2. High cholesterol71%
  3. High blood pressure68%
  4. Anxiety31%
  5. Mood disorders30%
  6. Osteoporosis29%
  7. Depression27%
  8. Ischemic heart disease27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Dellaripa's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women67%
  • Men32%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Paul F. Dellaripa wrote 2,021 Medicare Part D claims in 2024

In 2024, Dr. Dellaripa wrote 2,021 Medicare Part D claims for 287 patients. 74% of them were for generic drugs. CMS names the drug for 1,780 of them, across 39 drugs with 11 or more claims each, at $2,918,547 in total drug cost. In 2023, CMS named 1,636 claims across 33 drugs.

Part D claims, 20242,021
Drugs named by CMS39
Total drug cost$2.9M
Part D patients287

Dr. Dellaripa's Part D claims by kind of drug, 2024

  • Generic1,492 claims74%
  • Brand-name and other529 claims26%

Dr. Dellaripa's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Dellaripa's Part D claims, 2024

  • Opioids1%17 of 2,021 claims
  • Antibiotics1%28 of 2,021 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,6362024: 1,7809%

Drugs named by CMS: 39 in 2024, 33 in 2023.

See all prescribing by Dr. Dellaripa

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Paul F. Dellaripa offers telehealth to Medicare patients

Dr. Dellaripa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dellaripa as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find rheumatologists like Dr. Dellaripa by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Paul F. Dellaripa has 75 publications on record

Dmand AI links 75 papers to Dr. Dellaripa, published from 2010 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Lung Diseases, Interstitial, Arthritis, Rheumatoid and Lung. Dr. Dellaripa has published most often in Arthritis Rheumatol. Dr. Dellaripa's most frequent co-authors are Tracy Jennifer Doyle, MD, Jeffrey A. Sparks, MD and Nancy Ann Shadick, MD.

Papers75
Years published2010 to 2025

Dr. Dellaripa's papers by year, 2016 to 2025

Topics Dr. Dellaripa writes about most

  • Lung Diseases, Interstitial
  • Arthritis, Rheumatoid
  • Lung
  • Tomography, X-Ray Computed
  • Idiopathic Pulmonary Fibrosis
  • Lung Diseases
  • Rheumatic Diseases
  • Antirheumatic Agents

Dr. Dellaripa's most frequent co-authors

Recent publications by Dr. Dellaripa

See all 75 publications and co-authors

See who Dr. Dellaripa researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Dellaripa works with, so you can find a warm path to the right rheumatologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Paul F. Dellaripa has worked on 3 clinical trials

Dmand AI links Dr. Dellaripa to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Lung Diseases, Interstitial, Livedoid Vasculopathy and Myositis.

Clinical trials with Dr. Dellaripa by phase

  1. 1Early phase 1: 1 trial
  2. NonePhase 1: no trials
  3. 2Phase 2: 2 trials
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Dellaripa's trials

  • Lung Diseases, Interstitial
  • Livedoid Vasculopathy
  • Myositis
  • Scleroderma, Systemic
  • Raynaud Disease

Investigators on the most trials with Dr. Dellaripa

Recent clinical trials with Dr. Dellaripa

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Paul F. Dellaripa received $1,463 in industry payments in 2020

CMS Open Payments shows 4 general payments to Dr. Dellaripa from 1 drug or device company in 2020. Speaker and faculty fees make up the largest share, 100% of the total. Boehringer Ingelheim USA, Inc. paid the most, $1,463.

Companies that paid Dr. Dellaripa the most, 2020 to 2020

Share is of all general payments to this clinician.

See all payments to Dr. Dellaripa

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Paul F. Dellaripa graduated from University of Connecticut School of Medicine

Dr. Dellaripa graduated from University of Connecticut School of Medicine in 1989.

  1. Medical schoolUniversity of Connecticut School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Paul F. Dellaripa's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Paul F. Dellaripa

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Paul F. Dellaripa's NPI number?

Dr. Paul F. Dellaripa's NPI number is 1093727950. It was assigned on August 12, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Paul F. Dellaripa?

Dr. Paul F. Dellaripa is a rheumatologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Rheumatology Physician (taxonomy code 207RR0500X).

Where does Dr. Paul F. Dellaripa practice?

Dr. Dellaripa practices at 75 Francis Street, Boston, MA 02115. Dr. Dellaripa's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dmand AI also links Dr. Dellaripa to 3 hospitals, 2 medical groups, 1 group practice or clinic and 1 hospital outpatient department.

What is Dr. Paul F. Dellaripa's office phone number?

The practice phone on file for Dr. Dellaripa is (617) 732-5500.

What is Dr. Paul F. Dellaripa's medical license number?

Dr. Dellaripa holds Massachusetts license 76216.

Which hospitals is Dr. Paul F. Dellaripa affiliated with?

Dr. Dellaripa practices at Brigham and Women's Hospital in Boston, Massachusetts. Dr. Dellaripa is also affiliated with Massachusetts General Hospital. Dmand AI links Dr. Dellaripa to 3 more hospitals.

What medical group is Dr. Paul F. Dellaripa part of?

Dr. Dellaripa is linked to Brigham and Women's Hospital. Dmand AI links Dr. Dellaripa to 2 more medical groups.

Does Dr. Paul F. Dellaripa accept Medicare?

Yes. CMS data shows Dr. Dellaripa billed Medicare for 736 services in 2024, and Dr. Dellaripa accepts Medicare assignment.

Does Dr. Paul F. Dellaripa offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Dellaripa as offering telehealth services.

How many Medicare patients does Dr. Paul F. Dellaripa see?

CMS counts 430 Medicare patients who saw Dr. Dellaripa in 2024, with an average age of 73.

Show 7 more questionsShow fewer questions

What services does Dr. Paul F. Dellaripa bill to Medicare?

In 2024, Dr. Dellaripa's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and office visit, new patient (99203).

Where did Dr. Paul F. Dellaripa go to medical school?

Dr. Dellaripa graduated from University of Connecticut School of Medicine in 1989.

What drugs does Dr. Paul F. Dellaripa prescribe most?

In 2024 Medicare Part D data, Dr. Dellaripa's most prescribed drugs by claims were Methotrexate, Prednisone and Hydroxychloroquine Sulfate.

Has Dr. Paul F. Dellaripa received payments from drug or device companies?

CMS Open Payments shows $1,463 in general payments to Dr. Dellaripa from 1 company from 2020 to 2020. The largest total came from Boehringer Ingelheim USA, Inc.

How long has Dr. Paul F. Dellaripa been practicing?

Dr. Dellaripa graduated from medical school in 1989, 37 years ago.

Does Dr. Paul F. Dellaripa do research?

Dmand AI links 75 publications to Dr. Dellaripa, published from 2010 to 2025. Dr. Dellaripa has worked on 3 clinical trials.

Who does Dr. Paul F. Dellaripa publish with?

Dr. Dellaripa's most frequent co-authors are Tracy Jennifer Doyle, MD (36 shared papers), Jeffrey A. Sparks, MD (27 shared papers) and Nancy Ann Shadick, MD (16 shared papers).

Selling to rheumatology practices?

See rheumatologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)